IPO registrations (S-1, F-1) · Registrants

UNITED THERAPEUTICS Corp

SEC CIK
1082554 · filings on EDGAR ↗
Registration
Form S-1, first filed 1999-04-16, last 2000-01-14; 2 initial registrations, 5 amendments
Outcome
Final prospectus filed 2000-01-18
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1000 SPRING ST, Silver Spring, MD 20910
EIN
52-1984749
Ticker
UTHR (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
UNITED THERAPEUTICS Corp on the corporate pages

Offering terms

Final price
$32.00 per share (424B1 filed 2000-01-18, an initial public offering)
Shares sold
2,500,000
Gross proceeds
$80,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol UTHR

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 10

FiledFormWhat it isName as filedEDGAR
1999-04-16S-1S-1 (registration)UNITED THERAPEUTICS CORP0000950133-99-001367 ↗
1999-05-20S-1/AS-1/A (amendment)UNITED THERAPEUTICS CORP0000950133-99-001961 ↗
1999-06-10S-1/AS-1/A (amendment)UNITED THERAPEUTICS CORP0000950133-99-002148 ↗
1999-06-11S-1/AS-1/A (amendment)UNITED THERAPEUTICS CORP0000950133-99-002168 ↗
1999-06-15S-1/AS-1/A (amendment)UNITED THERAPEUTICS CORP0000950133-99-002201 ↗
1999-12-30S-1S-1 (registration)UNITED THERAPEUTICS CORP0000950133-99-004047 ↗
2000-01-14S-1/AS-1/A (amendment)UNITED THERAPEUTICS CORP0000950133-00-000073 ↗
2000-01-18424B1424B1 (final prospectus)UNITED THERAPEUTICS CORP0000950133-00-000103 ↗
2000-04-04424B1424B1 (final prospectus)UNITED THERAPEUTICS CORP0000950133-00-001405 ↗
2000-06-26424B1424B1 (final prospectus)UNITED THERAPEUTICS CORP0000950133-00-002681 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-01-14S-1/Aregistration statement$32.002,500,000$80,000,000Nasdaq UTHR0from the submission text; price sentence, shares headline, proceeds computeddocument ↗
2000-01-18424B1final prospectus$32.002,500,000$80,000,000Nasdaq UTHR0from the submission text; price sentence, shares headline, proceeds computeddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
HADEED FRED TOfficerEVP, Business Development; EVP & CFO162006
JEFFS ROGERDirector,Officer; OtherPresident 7 COO; President and COO; President & CO); President & Co-CEO; President & Coo; President & COO3142006–2016
MAHON PAUL ADirector,Officer; OfficerEVP and General Counsel; EVP & CFO; EVP & General Counsel; EVP & GENERAL COUNSEL4362006–2026
ROTHBLATT MARTINE ADirector; Director,Officer; OfficerCEO; Chairman & CEO; Chairman & Co-CEO; Chairperson & CEO; CHAIRPERSON & CEO1,0052006–2026
KURZWEIL RAYDirector512006–2026
CAUSEY CHRISTOPHERDirector1882006–2026
DWEK RAYMONDDirector1102006–2025
GRAY R PAULDirector; Other402006–2014person page Fuzzy
PATUSKY CHRISTOPHERDirector1182006–2026
SULLIVAN LOUIS WDirector642006–2026
Ferrari John MaximOfficer; OtherCFO; CFO & Treasurer; Chief Financial Officer1052006–2015
LILLY ELI & COTenPercentOwnerDirector, Chairman and CEO42008–2011
Giltner RichardDirector602009–2026
Thompson Tommy GDirector652010–2026
Klein Katherine JDirector162014–2024
ZACCARDELLI DAVIDOfficer; OtherEVP & Chief Operating Officer522015–2016
EDGEMOND JAMESOfficerCFO and Treasurer; CFO AND TREASURER642015–2026
Olian Judy D.Director402015–2026
BENKOWITZ MICHAELOfficerPresident and COO; PRESIDENT AND COO992016–2026
Mesa NildaDirector302018–2026
MAXWELL LINDADirector92020–2026
MALCOLM JANDirector152024–2026
Tracey KevinDirector32026
DZAU VICTOR JDirector22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationUnited Therapeutics CorporationMDState business registriesname and state
Business registrationUNITED THERAPEUTICS CORPORATIONMDState business registriesEIN (EXACT, as the state registration reports it)
Business registrationUNITED THERAPEUTICS CORPORATIONMDState business registriesname and state
Business registrationUNITED THERAPEUTICS CORPORATIONMDState business registriesname and state
Federal award recipientUNITED THERAPEUTICS CORPMDFederal spending (USAspending)name and state
Lobbying clientUNITED THERAPEUTICSMDFederal lobbying (LDA)name and state
Lobbying clientUNITED THERAPEUTICS CORPORATIONMDFederal lobbying (LDA)name and state
Patent assigneeUnited Therapeutics CorporationMDPatents (USPTO)name and state
SEC filerUNITED THERAPEUTICS CorpSEC filers (EDGAR)CIK (EXACT)
Trademark ownerUnited Therapeutics CorporationMDTrademarks (USPTO)name and state
Form 5500 plan sponsorUNITED THERAPEUTICS CORPORATIONEIN (EXACT)
Person pageR Paul GrayPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MD first:

More with this interest.

In other datasets, the same topic (Health) in MD:

Interests: Pharmaceutical Preparations · Health